Search

Heat waves are increasing in severity, duration, and frequency. The Multi-Scenario Extreme Weather Simulator (MEWS) models this using historical data, climate model outputs, and heat wave multipliers. In this study, MEWS is applied for planning of a community resilience hub in Hau'ula, Hawaii. The hub will have normal operations and resilience operations modes. Both these modes were modeled using EnergyPlus. The resilience operations mode includes cutting off air conditioning for many spaces to decrease power requirements during emergencies. Results were simulated for 300 future weather files generated by MEWS for 2020, 2040, 2060, and 2080. Shared socioeconomic pathways 2–4.5, 3–7.0 and 5–8.5 were used. The resilience operations mode results show two to six times increase of hours of exceedance beyond 32.2 °C from present conditions, depending on climate scenario and future year. The resulting decrease in thermal resilience enables an average decrease of energy use intensity of 26% with little sensitivity to climate change. The decreased thermal resilience predicted in the future is undesirable, but was not severe enough to require a more energy-intensive resilience mode. Instead, planning is needed to assure vulnerable individuals are given prioritized access to air-conditioned parts of the hub if worst-case heat waves occur. [ABSTRACT FROM AUTHOR]

Detection rate of de novo EGFR T790 M mutation was increased up to 80% through recent ultrasensitive detection methods. Here, we investigated the clinical significance and its usefulness of detecting de novo EGFR T790 M using ultrasensitive droplet-digital polymerase chain reaction (ddPCR) method. In total, 102 cases diagnosed as lung adenocarcinoma with EGFR-tyrosine kinase inhibitor (TKI) sensitizing mutations (mEGFR) and had been treated with 1st ~ 2nd generation EGFR-TKI alone were enrolled for this study. De novo T790 M status was tested using the tissues at the initial diagnosis and positivity was defined as the ratio of T790 M/wild-type copies over 0.00294 by ddPCR. Seventy patients (68.6%) harbored the de novo T790 M. De novo T790 M was more frequently detected in cases with EGFR L858 R mutation than those with EGFR exon 19 deletion (E19d) mutations (P = 0.024). Forty-three patients underwent rebiopsy due to disease progression. The cases who experienced progression due to acquired T790 M were more likely to have E19d at initial diagnosis and the presence of de novo T790 M and the ratio of T790 M/wild-type copies did not relate to the emergence of acquired T790 M. On the other hand, the cases with a longer duration of disease-control by EGFR-TKI had higher change to get acquired T790 M mutation (P-value = 0.040). The presence of de novo T790 M has limitation in predicting disease progression by acquired T790 M, suggesting that identifying de novo T790 M through the ultrasensitive methods may not be necessary identifying patients who would be beneficial by 3rd-generation EGFR-TKI as the 1st line treatment. [ABSTRACT FROM AUTHOR]

The purposes of this study are to confirm the role of Fibroblast Growth Factor-2 (FGF-2) in bone regeneration by adding various concentrations of FGF-2 to the collagen membrane and applying it to the Biphasic Calcium Phosphate (BCP) bone graft site for guided bone regeneration, to explore the potential of collagen membrane as FGF-2 carrier, and to determine the optimum FGF concentration for enhancement of bone regeneration. Four bone defects of 8 mm in diameter were created in 18 New Zealand rabbit calvaria. After BCP bone graft, graft material was covered with collagen membranes adding various concentration of FGF-2. The concentration of FGF-2 was set at 1.0, 0.5, 0.1 mg/ml, and same amount of saline was used in the control group. To confirm the bone regeneration over time, six New Zealand rabbits were sacrificed each at 2, 4, and 12 weeks, and the amounts of new bone and residual bone graft material were analyzed by histologic and histomorphometric analysis. Qualitative analyses are also conducted through immunohistochemistry, Tetrate-resistant acid phosphatase (TRAP) stain and Russell-Movat pentachrome stain. As the healing period increased, the formation of new bone increased and the amount of residual graft material decreased in all experimental groups. Immunohistochemistry, TRAP staining and pentachrome staining further showed that the addition of FGF-2 promoted bone regeneration in all experimental groups. It was also confirmed that polymer collagen membrane can be used as a useful carrier of FGF-2 when enhanced early stage of new bone formation is required. [ABSTRACT FROM AUTHOR]

The aim of this study was to investigate the phenolic acid and carotenoid composition of bitter melon and to evaluate its antioxidant activity. The harvest starts from 5-35 days after fertilization. With increasing maturation, gallic acid, chlorogenic acid, and catechin contents increased, while caffeic acid, p-coumaric acid, and ferulic acid contents decreased. With increasing maturation, all carotenoids contents increased. Although lycopene content was not detected for 20 days after fertilization, its content increased to 842.0 μg/g at 35 days after fertilization. Total polyphenol and flavonoid contents were increased to 639.4 and 203.3 mg/100 g after 35 days. Free radical scavenging activities increased with increasing maturation. This suggests that bitter melon is a good source of natural antioxidants and might have potential health benefits for consumers as a functional food or value-added ingredient. [ABSTRACT FROM AUTHOR]

Nutritional status affects the prognosis of various tumors. The prognostic nutritional index (PNI) is the known predictor of postoperative outcome in resectable pancreatic cancer patients. This study aimed to validate the prognostic value of PNI in all stages of pancreatic cancer. We retrospectively reviewed 499 patients with pancreatic cancer who were diagnosed at Severance Hospital between January 2006 and December 2011. The PNI value was calculated as 10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (/mm3) at initial diagnosis. The median patient age was 62 yr, and 289 were men. The study group comprised resectable disease (n = 121), locally advanced disease (n = 118), and metastatic disease (n = 260). Univariate and multivariate analysis revealed that PNI ≤ 49.5 at initial diagnosis, together with performance status, platelet count, and clinical stage, was significantly associated with overall survival (hazard ratio, 1.562; all P < 0.05). Patients with PNI ≤ 49.5 (n = 208) had shorter median overall survival compared to patients with high PNI (9.8 vs. 14.2 mo; log rank, P < 0.001). In clinical stage subgroup analysis, initial PNI ≤49.5 independently predicted shorter overall survival, especially in resectable and metastatic disease (P = 0.041, P = 0.002, respectively). [ABSTRACT FROM AUTHOR]

In this paper, we fabricated and evaluated a flowmeter with a sub-micron sized piezoresistive layer for the measurement in the small area. For the small area detection, the sensing material should be reduced as well as sensor body. We use the FIB system to reduce the size of the sensing material and obtain the sub-micron sized line width. The device is fabricated with the standard MEMS process, and the platinum layer is selected as the piezoresistive material considering the electrical conductivity. The 0∼4m/s air flows are applied to the flowmeter and the experimental results shows the negative sensitivity output with -3.22E−5/ms−1. This negative value is due to the additional materials like carbon and gallium. The various experiments including stability and repeatability are performed, and the repeated operation shows stable output signals with less than 9.6% variation. Through those experiment results, the FIB assisted platinum layer is suitable for the piezoresistive detection and a flowmeter can be applied to measurement of flow rate in the small area. [ABSTRACT FROM AUTHOR]

Adipose stem cells (ASCs) are detectable in the parenchyma and large airways of lungs after systemic administration, and ameliorate inflammatory infiltration and cell death in animal models of emphysema. We evaluated whether ASC treatment could attenuate lung fibrosis induced by repetitive intratracheal bleomycin administration. Male 8-week-old C57BL/6J mice (control group, bleomycin-only group, and bleomycin-plus-ASC group) were used. Eight biweekly doses of bleomycin were injected intratracheally via an intubation procedure at a dose of 0.04 units in a total volume of 100 μL of sterile saline. During the latter 2 months of the 4-month bleomycin exposure, human ASCs (3 × 105 cells) were administered repeatedly via intraperitoneal injection at the same time as bleomycin. Lung tissues were evaluated for histology, collagen content, TUNEL staining, and TGF-β levels. Bronchoalveolar lavage (BAL) was performed for cell counting. Administrations of ASCs ameliorated the deleterious effects of repetitive intratracheal instillation of bleomycin, namely hyperplasia of Club cells (Clara cells) and cuboidal alveolar epithelial cells, infiltration of the perialveolar ducts by inflammatory cells, septal thickening, enlarged alveoli, and extensive fibrosis. Addition of ASC led to suppression of bleomycin-induced epithelial cell apoptosis and expression of TGF-β. These results suggest a useful therapeutic effect of ASCs on pulmonary fibrosis induced by repetitive bleomycin administration. Further studies will be required to evaluate the efficacy of ASC therapy for the treatment of idiopathic pulmonary fibrosis. [ABSTRACT FROM AUTHOR]

We fabricated and evaluated a flowmeter with a corrugation structure for various applications. The device measures the air flow rate using the air drag force, and the corrugation structure is adopted for the more deformation which brings the higher sensitivity. The flowmeter is fabricated with standard CMOS process, and the strain is measured with the piezoresistive material, platinum. The fabricated flowmeter measures the small air flow rate to 0.2 m/s and has a wide measurement range up to 7 m/s. The stability and repeatability characteristics are investigated, and around 5% uniform results are obtained. The flowmeter is used for the 2-dimensional measurement, and the air flow rate and direction are determined with the compensated vector calculation. [ABSTRACT FROM PUBLISHER]

This study highlights the potential of four commercially available granular-activated carbons (GACs) to remove Methyl tert-butyl ether (MTBE) from an aqueous medium. Thermodynamics and kinetics parameters were elucidated. The FT-IR spectra showed decrease in peak intensity after the adsorption. The decline in the peak intensity revealed that the adsorption occurred on available active sites over the surface of the GACs. The adsorption on GACs was maximum in the pH range 7-8, with maximum adsorption capacity (47.82 mg/g, pH 8) observed with CGAC. The contact time studies showed optimum adsorption of MTBE on CGAC (67.05 mg/g) at 300 mg/L initial MTBE concentration. The applicability of the Freundlich model illustrates a multilayer adsorption process. The adsorption process is endothermic in nature. The kinetics studies showed that the adsorption follows the pseudo-second-order model on GACs and the intraparticle diffusion is the rate-controlling mechanism on CGAC. [ABSTRACT FROM AUTHOR]

Bone destruction is known to be an important cause of complications in chronic cholesteatomatous otitis media. A strategy that blocks localized bone resorption may prevent the progression of the disease. The bisphosphonate drug pamidronate is known to inhibit bone resorption and has been used in the treatment of Paget's disease and osteoporosis. The aim of this study was to investigate the effect of pamidronate on the inhibition of bone resorption in cholesteatoma using a neonatal rat calvarial culture system. Radioactive calcium was subcutaneously injected into pregnant rats. Neonatal calvariae were harvested after i.p. injection of pamidronate disodium to neonatal rats and culture supernatants of cholesteatoma keratinocytes were then added to the calvarial culture media. Radioactive calcium release was measured using a beta-ray scintillation counter. The percentage of calcium release was significantly higher in cholesteatoma culture supernatant than in Dulbecco's modification of Eagle's medium. The percentage calcium release in cholesteatoma culture supernatant was significantly lower with the high dose of pamidronate than with the low dose. These results suggest that pamidronate can inhibit the bone resorption caused by cholesteatoma. This study suggests a possible application for pamidronate in the prevention of cholesteatomatous bone destruction. [ABSTRACT FROM AUTHOR]

We investigated the influence of high hydrostatic pressure (HHP) treatment on the estrogenic properties and conversion of the phenolic compounds in germinated black soybean. The black soybean was germinated for two- or four-days, and then subjected to HHP at 0.1, 50, 100, or 150 MPa for 12 or 24 h. The highest total polyphenol content (3.9 mg GAE/g), flavonoid content (0.8 mg CE/g), phenolic acid content (940 ± 18.96 μg/g), and isoflavonone content (2600 μg/g) were observed after germination for four days and HHP treatment at 100 MPa for 24 h. In terms of isoflavone composition, the malonyl, acetyl and β-glycoside contents decreased, while the aglycone content increased with HHP. The highest proliferative effect (150%) is observed at four days germination and HHP treatment at 100 MPa. These results suggest that application of HHP may provide useful information regarding the utility of black soybean as alternative hormone replacement therapy. [ABSTRACT FROM AUTHOR]

Over half of commercial building floor area in the US is served by packaged rooftop units (RTUs). With a typical useful life in the 10-20 years range, RTU replacement is a periodic necessity in commercial buildings and an opportunity for upgrading to higher-efficiency units. We designed a package of energy efficiency measures that can be used in conjunction with an RTU replacement, including advanced controls, high-efficiency low pressure-drop air filters, energy monitoring and, optionally, window films and cool-roofs to reduce loads and size of the replacement RTUs. We conducted side-by-side laboratory testing of the package to evaluate energy savings and thermal comfort relative to an existing building baseline. Daily HVAC energy savings for the RTU replacement package averaged 61% across all seasons. The test data showed that the ASHRAE Guideline 36 controls significantly reduced thermal loads and this was a key contributor to the savings, in addition to the higher efficiency of the RTU itself. The laboratory testing also revealed some challenges with installation and commissioning of Guideline 36. Overall, the results demonstrate that significant savings can be realized in existing office buildings by incorporating relatively low-risk, proven measures in conjunction with an RTU replacement. [ABSTRACT FROM AUTHOR]

The present study aimed to develop the sustained-release oral dosage form of pelubiprofen (PEL) by using the blended mixture of 3-aminopropyl functionalized-magnesium phyllosilicate (aminoclay) and pH-independent polymers. The sustained-release solid dispersion (SRSD) was prepared by the solvent evaporation method and the optimal composition of SRSD was determined as the weight ratio of drug: Eudragit® RL PO: Eudragit® RS PO of 1:1:2 in the presence of 1% of aminoclay (SRSD(F6)). The dissolution profiles of SRSD(F6) were examined at different pHs and in the simulated intestinal fluids. The drug release from SRSD(F6) was limited at pH 1.2 and gradually increased at pH 6.8, resulting in the best fit to Higuchi equation. The sustained drug release from SRSD(F6) was also maintained in simulated intestinal fluid at fasted-state (FaSSIF) and fed-state (FeSSIF). The structural characteristics of SRSD(F6) were examined by using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR), indicating the change of drug crystallinity to an amorphous form. After oral administration in rats, SRSD(F6) exhibited the prolonged drug exposure in plasma. For both PEL and PEL-transOH (active metabolite), once a day dosing of SRSD(F6) achieved oral exposure (AUC) comparable to those from the multiple dosing (3 times a day) of untreated drug. In addition, thein vivoabsorption of SRSD(F6) was well-correlated with thein vitrodissolution data, establishing a good level Ain vitro/in vivocorrelation. These results suggest that SRSD(F6) should be promising for the sustained-release of PEL, thereby reducing the dosing frequency. [ABSTRACT FROM AUTHOR]

The purpose of this study was to investigate doctors' and patients' perceptions of cervical intraepithelial neoplasia 1 (CIN 1) and its treatment methods. A survey questionnaire was offered to obstetrics and gynaecology doctors and patients with CIN 1 in 2017. Only 43% of patients knew of this disease. Regarding perceptions of its aetiology, 64% of the patients perceived human papillomavirus infection to be the main cause of CIN 1. Patients' most preferred treatments were medication (20%), followed by alternative treatment (14%). Among doctors, regular follow-up was the most preferred method for managing CIN 1. The survey showed that current treatment modalities for CIN 1 were satisfactory to only half of doctors (50%) and patients (53%). Overall, 70% of doctors responded that new drug development for CIN 1 is needed. Although, CIN 1 is a low-grade lesion, doctors and patients expressed the desire for new therapeutic agents to manage it.IMPACT STATEMENTWhat is already known on this subject? In general, treatment is not recommended for CIN 1 because lesions are considered indicative of transient HPV infection and spontaneously regress in most patients.What do the results of this study add? Regular follow-up for CIN 1 were satisfactory to only half of doctors and patients. Thirty-six percent of patients wanted active treatment instead of regular follow-up. In addition, 70% of doctors responded that new drug development for CIN 1 is needed.What are the implications of these findings for clinical practice and/or further research? Our results support the need for therapeutic agents for CIN 1. [ABSTRACT FROM AUTHOR]

Hyperthermia, the procedure of raising the temperature of tumor-loaded tissue to 40°-43°C, has been applied to various established cancer treatments. Although the mechanism of hyperthermia in cancer treatment is well-known, there are few or no studies regarding the effect of hyperthermia on the tumor-supportive stroma. Mesenchymal stem cells (MSCs) display the potential for differentiation into various tissues. MSCs are also reported to play a role as potential precursors for tumor stroma in providing a favorable environment for tumor progression. Here, we investigated the effects of hyperthermia-treated MSCs on the viability and growth of cancer cells. Culture supernatants from non-shocked or heat-shocked MSCs (NS-MSCs or HS-MSCs) were added to MCF7 cells. Morphological analysis and cell proliferation assay showed the reduced viability and growth of MCF7 cells by addition of culture medium conditioned by HS-MSCs. Additionally, exposure to the conditioned medium by HS-MSCs induced cell cycle arrest at G2/M phase, increased MHC class I, Fas receptor, and TNF-R expressions, and decreased MDR1 expression in the MCF7 cells. In particular, the conditioned medium of HS-MSCs accelerated the inhibition of tumor cell growth by several chemotherapeutic drugs. These data present new aspects of hyperthermia in cancer treatment, suggesting that hyperthermia can enable tumor stroma provide a sensitizing environment for tumor cells to undergo cell death. [ABSTRACT FROM AUTHOR]